HIV News and Research

RSS

Study could help prevent HIV/AIDS and pregnancy among South African adolescent girls

An important new finding by University of Cincinnati researchers could help slow the transmission of HIV/AIDS and reduce pregnancies among adolescent girls in rural South Africa.

22 Dec 2020

Study measures the effects of HIV infection on development of cervical cancer

A research team at the Technical University of Munich (TUM) has quantified the effects of an infection with the Human Immunodeficiency Virus (HIV) on the development of cervical cancer.

22 Dec 2020

Cannabis use during opioid addiction treatment may reduce fentanyl exposure

New research suggests that cannabis use by people in care for opioid addiction might improve their treatment outcomes and reduce their risk of being exposed to fentanyl in the contaminated unregulated drug supply.

21 Dec 2020

Research may lead to better treatment and vaccines for Ebola, COVID-19

In the midst of a global pandemic with COVID-19, it's hard to appreciate how lucky those outside of Africa have been to avoid the deadly Ebola virus disease.

21 Dec 2020

Researchers propose strategy to detect and intercept diseases emerging from wildlife

A University of Arkansas biologist is part of a global team of researchers developing a strategy to detect and intercept diseases emerging from wildlife in Africa that could eventually infect humans.

18 Dec 2020

West Nile virus-infected mosquitoes are abundant in lower-income areas of Baltimore

In a new study published in the Journal of Medical Entomology, researchers at the University of Maryland (UMD) found higher rates of West Nile virus-infected mosquitoes in lower-income neighborhoods in urban areas of Baltimore, Maryland.

18 Dec 2020

Vi-DT typhoid conjugate vaccine met primary endpoints in phase III study

Vi-DT typhoid conjugate vaccine, developed jointly by the International Vaccine Institute (IVI) and SK bioscience, has met the primary endpoints in a phase III study in Nepal.

17 Dec 2020

Research shows that people affected with COVID-19 suffer from cognitive effects

More and more evidence is coming out that people with COVID-19 are suffering from cognitive effects, such as brain fog and fatigue.

17 Dec 2020

Supercomputer simulations lead to an important viral inhibitor discovery

University of New Hampshire researchers recently used Comet at the San Diego Supercomputer Center at UC San Diego and Stampede2 at the Texas Advanced Computing Center to identify new inhibitor binding/unbinding pathways in an RNA-based virus.

17 Dec 2020

Cholesterol in the plasma membrane is essential for SARS-CoV-2 entry and syncytia formation

A preprint indicates that SARS-CoV-2 requires cholesterol to accomplish entry into the host cells and membrane fusion.

17 Dec 2020

PrEP prescription can make a positive difference in women who inject drugs

When taken daily, pre-exposure prophylaxis, or PrEP, is a highly effective way to prevent HIV transmission, according to the Centers for Disease Control and Prevention.

16 Dec 2020

SARS-CoV-2 RNA can be reverse-transcribed to be part of chimeric viral-human genome

A new study reveals that the genome of SARS-CoV-2 is inserted into the human genome, accounting for the detection of viral RNAs.

16 Dec 2020

Impaired blood vessel and kidney function underlie heart disease risk in people with HIV

A new study has found impaired blood vessel function in those living with human immunodeficiency virus (HIV).

16 Dec 2020

New method shortens the timeline to generate mice for vaccine research

To develop vaccines and investigate human immune responses, scientists rely on a variety of animal models, including mice that can produce human antibodies through genetically engineered B cell receptors, which are specialized antibodies bound to the B cell membrane.

14 Dec 2020

Prior T cell immunity to SARS-CoV-2 unlikely to be the result of seasonal coronavirus infection

Scientists have suggested that a proportion of the population have pre-existing immunity to COVID-19 because of T cells primed against SARS-CoV-2 antigens.

14 Dec 2020

Texas Biomed to investigate the effects of cannabinoids on HIV-associated neurocognitive disorder

The National Institutes of Health (NIH) awarded Professor Mahesh Mohan, D.V.M., Ph.D., and collaborators more than $3.5 million over five years to investigate the effects of cannabinoids on Human Immunodeficiency Virus (HIV) associated neurocognitive disorder (HAND).

11 Dec 2020

HIV News and Research

Study could help prevent HIV/AIDS and pregnancy among South African adolescent girls

Study measures the effects of HIV infection on development of cervical cancer

Cannabis use during opioid addiction treatment may reduce fentanyl exposure

Research may lead to better treatment and vaccines for Ebola, COVID-19

Researchers propose strategy to detect and intercept diseases emerging from wildlife

West Nile virus-infected mosquitoes are abundant in lower-income areas of Baltimore

Vi-DT typhoid conjugate vaccine met primary endpoints in phase III study

Research shows that people affected with COVID-19 suffer from cognitive effects

Supercomputer simulations lead to an important viral inhibitor discovery

Cholesterol in the plasma membrane is essential for SARS-CoV-2 entry and syncytia formation

PrEP prescription can make a positive difference in women who inject drugs

SARS-CoV-2 RNA can be reverse-transcribed to be part of chimeric viral-human genome

Impaired blood vessel and kidney function underlie heart disease risk in people with HIV

New method shortens the timeline to generate mice for vaccine research

Prior T cell immunity to SARS-CoV-2 unlikely to be the result of seasonal coronavirus infection

Texas Biomed to investigate the effects of cannabinoids on HIV-associated neurocognitive disorder

Researchers use AI platform to identify best combination of available therapies against COVID-19.

IGC researchers receive three out of six European Research Council grants

Using AI to find optimal combination of available therapies against SARS-CoV-2

Hydroxychloroquine found ineffective as post-exposure SARS-CoV-2 prophylaxis

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News